BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 10422789)

  • 21. Cannabinoid CB(1) receptor expression, activation and detection of endogenous ligand in trabecular meshwork and ciliary process tissues.
    Stamer WD; Golightly SF; Hosohata Y; Ryan EP; Porter AC; Varga E; Noecker RJ; Felder CC; Yamamura HI
    Eur J Pharmacol; 2001 Nov; 431(3):277-86. PubMed ID: 11730719
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CB1 receptor-independent actions of SR141716 on G-protein signaling: coapplication with the mu-opioid agonist Tyr-D-Ala-Gly-(NMe)Phe-Gly-ol unmasks novel, pertussis toxin-insensitive opioid signaling in mu-opioid receptor-Chinese hamster ovary cells.
    Cinar R; Szücs M
    J Pharmacol Exp Ther; 2009 Aug; 330(2):567-74. PubMed ID: 19448142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Agonist-directed trafficking of response by endocannabinoids acting at CB2 receptors.
    Shoemaker JL; Ruckle MB; Mayeux PR; Prather PL
    J Pharmacol Exp Ther; 2005 Nov; 315(2):828-38. PubMed ID: 16081674
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stimulation of cannabinoid receptor CB1 induces krox-24 expression in human astrocytoma cells.
    Bouaboula M; Bourrié B; Rinaldi-Carmona M; Shire D; Le Fur G; Casellas P
    J Biol Chem; 1995 Jun; 270(23):13973-80. PubMed ID: 7775459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Virodhamine and CP55,940 modulate cAMP production and IL-8 release in human bronchial epithelial cells.
    Gkoumassi E; Dekkers BG; Dröge MJ; Elzinga CR; Schmidt M; Meurs H; Zaagsma J; Nelemans SA
    Br J Pharmacol; 2007 Aug; 151(7):1041-8. PubMed ID: 17558435
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of nitric oxide production in RAW264.7 macrophages by cannabinoids and palmitoylethanolamide.
    Ross RA; Brockie HC; Pertwee RG
    Eur J Pharmacol; 2000 Aug; 401(2):121-30. PubMed ID: 10924916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SR147778 [5-(4-bromophenyl)-1-(2,4-dichlorophenyl)-4-ethyl-N-(1-piperidinyl)-1H-pyrazole-3-carboxamide], a new potent and selective antagonist of the CB1 cannabinoid receptor: biochemical and pharmacological characterization.
    Rinaldi-Carmona M; Barth F; Congy C; Martinez S; Oustric D; Pério A; Poncelet M; Maruani J; Arnone M; Finance O; Soubrié P; Le Fur G
    J Pharmacol Exp Ther; 2004 Sep; 310(3):905-14. PubMed ID: 15131245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cannabinoid modulation of rat pup ultrasonic vocalizations.
    McGregor IS; Dastur FN; McLellan RA; Brown RE
    Eur J Pharmacol; 1996 Oct; 313(1-2):43-9. PubMed ID: 8905327
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SR 144528, an antagonist for the peripheral cannabinoid receptor that behaves as an inverse agonist.
    Portier M; Rinaldi-Carmona M; Pecceu F; Combes T; Poinot-Chazel C; Calandra B; Barth F; le Fur G; Casellas P
    J Pharmacol Exp Ther; 1999 Feb; 288(2):582-9. PubMed ID: 9918562
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 3-Substituted pyrazole analogs of the cannabinoid type 1 (CB₁) receptor antagonist rimonabant: cannabinoid agonist-like effects in mice via non-CB₁, non-CB₂ mechanism.
    Wiley JL; Selley DE; Wang P; Kottani R; Gadthula S; Mahadeven A
    J Pharmacol Exp Ther; 2012 Feb; 340(2):433-44. PubMed ID: 22085649
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Allosteric modulator ORG27569 induces CB1 cannabinoid receptor high affinity agonist binding state, receptor internalization, and Gi protein-independent ERK1/2 kinase activation.
    Ahn KH; Mahmoud MM; Kendall DA
    J Biol Chem; 2012 Apr; 287(15):12070-82. PubMed ID: 22343625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cannabinoid CB1 receptors fail to cause relaxation, but couple via Gi/Go to the inhibition of adenylyl cyclase in carotid artery smooth muscle.
    Holland M; John Challiss RA; Standen NB; Boyle JP
    Br J Pharmacol; 1999 Oct; 128(3):597-604. PubMed ID: 10516638
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of two cloned human CB1 cannabinoid receptor isoforms.
    Rinaldi-Carmona M; Calandra B; Shire D; Bouaboula M; Oustric D; Barth F; Casellas P; Ferrara P; Le Fur G
    J Pharmacol Exp Ther; 1996 Aug; 278(2):871-8. PubMed ID: 8768742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pre-exposure to the cannabinoid receptor agonist CP 55940 enhances morphine behavioral sensitization and alters morphine self-administration in Lewis rats.
    Norwood CS; Cornish JL; Mallet PE; McGregor IS
    Eur J Pharmacol; 2003 Mar; 465(1-2):105-14. PubMed ID: 12650839
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LY320135, a novel cannabinoid CB1 receptor antagonist, unmasks coupling of the CB1 receptor to stimulation of cAMP accumulation.
    Felder CC; Joyce KE; Briley EM; Glass M; Mackie KP; Fahey KJ; Cullinan GJ; Hunden DC; Johnson DW; Chaney MO; Koppel GA; Brownstein M
    J Pharmacol Exp Ther; 1998 Jan; 284(1):291-7. PubMed ID: 9435190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Signaling pathway associated with stimulation of CB2 peripheral cannabinoid receptor. Involvement of both mitogen-activated protein kinase and induction of Krox-24 expression.
    Bouaboula M; Poinot-Chazel C; Marchand J; Canat X; Bourrié B; Rinaldi-Carmona M; Calandra B; Le Fur G; Casellas P
    Eur J Biochem; 1996 May; 237(3):704-11. PubMed ID: 8647116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Signal transduction of cannabinoid CB1 receptors in a smooth muscle cell line.
    Begg M; Baydoun A; Parsons ME; Molleman A
    J Physiol; 2001 Feb; 531(Pt 1):95-104. PubMed ID: 11179394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypersensitization of the Orexin 1 receptor by the CB1 receptor: evidence for cross-talk blocked by the specific CB1 antagonist, SR141716.
    Hilairet S; Bouaboula M; Carrière D; Le Fur G; Casellas P
    J Biol Chem; 2003 Jun; 278(26):23731-7. PubMed ID: 12690115
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Examination of the effect of the cannabinoid receptor agonist, CP 55,940, on electrically evoked transmitter release from rat brain slices.
    Gifford AN; Samiian L; Gatley SJ; Ashby CR
    Eur J Pharmacol; 1997 Apr; 324(2-3):187-92. PubMed ID: 9145770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rimonabant, a potent CB1 cannabinoid receptor antagonist, is a Gα
    Porcu A; Melis M; Turecek R; Ullrich C; Mocci I; Bettler B; Gessa GL; Castelli MP
    Neuropharmacology; 2018 May; 133():107-120. PubMed ID: 29407764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.